Acorah Software Products - Accounts Production 16.5.460 true true 30 September 2024 1 October 2023 false true No description of principal activity 1 October 2024 30 September 2025 30 September 2025 10377865 Mr Nuri Eldursi iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 10377865 2024-09-30 10377865 2025-09-30 10377865 2024-10-01 2025-09-30 10377865 frs-bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 10377865 frs-bus:FilletedAccounts 2024-10-01 2025-09-30 10377865 frs-bus:Micro-entities 2024-10-01 2025-09-30 10377865 frs-bus:EntityHasNeverTraded 2024-10-01 2025-09-30 10377865 frs-bus:AuditExempt-NoAccountantsReport 2024-10-01 2025-09-30 10377865 frs-bus:Director1 2024-10-01 2025-09-30 10377865 2023-09-30 10377865 2024-09-30 10377865 2023-10-01 2024-09-30
Registered number: 10377865
Science Of Man International Ltd
Unaudited Financial Statements
For The Year Ended 30 September 2025
Lotuswise
Lotuswise Suite, Ferrari House
258 Field End Road
Eastcote
HA4 9UU
Balance Sheet
Registered number: 10377865
2025 2024
£ £
Current assets 100 100
NET CURRENT ASSETS 100 100
TOTAL ASSETS LESS CURRENT LIABILITIES 100 100
NET ASSETS 100 100
CAPITAL AND RESERVES 100 100

Notes

1. General Information
Science Of Man International Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 10377865 . The registered office is 34 Stillington Crescent, Leicester, Leicestershire, England, LE5 1BR.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2024: 1)
1 1
For the year ending 30 September 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr Nuri Eldursi
Director
30 September 2025